BlackRock’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
BlackRock's BLSM Position: Q3 2026 in Review
BlackRock opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 147,686 shares worth $2.75M. The stake represents ﹤0.01% of the portfolio and ranks #4104 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- BlackRock held 147,686 shares of BlossomHill Therapeutics worth $2.75M as of Q3 2026.
- BlossomHill Therapeutics was a new BlackRock position in Q3 2026.
- BlossomHill Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #4104 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.